Cargando…

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma

SIMPLE SUMMARY: Glioblastoma is one of the most treatment-refractory human malignancies, and despite techniques that have allowed scientists and clinicians to better understand the molecular underpinnings of resistance, little progress has been made in improving the survival of patients with gliobla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Alexander, Ott, Martina, Fang, Dexing, Heimberger, Amy B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865703/ https://www.ncbi.nlm.nih.gov/pubmed/33498872 http://dx.doi.org/10.3390/cancers13030437

Ejemplares similares

MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020)

The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
por: Fahmideh, Hanieh, et al.
Publicado: (2022)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
por: Sooreshjani, Moloud, et al.
Publicado: (2023)

The role of JAK-STAT signaling within the CNS
por: Nicolas, Celine S., et al.
Publicado: (2013)

JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
por: Godoi, Mariely A., et al.
Publicado: (2023)

Targeting the tumor microenvironment: JAK-STAT3 signaling
por: Bournazou, Eirini, et al.
Publicado: (2013)

Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
por: Boudreau, C. Elizabeth, et al.
Publicado: (2021)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
por: Morgan, Ethan L., et al.
Publicado: (2020)

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
por: Sarapultsev, Alexey, et al.
Publicado: (2023)

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
por: Rusek, Marta, et al.
Publicado: (2023)

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022)

JAK-STAT signaling and myocardial glucose metabolism
por: Frias, Miguel A, et al.
Publicado: (2013)

Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
por: Park, Hyunjung, et al.
Publicado: (2023)

The role of interleukin-6-STAT3 signalling in glioblastoma
por: West, Alice J., et al.
Publicado: (2018)

Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases
por: Clément, Flora, et al.
Publicado: (2021)

Effects of JAK2-STAT3 signaling after cerebral insults
por: Raible, Daniel J, et al.
Publicado: (2014)

Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
por: Bose, Sankhadip, et al.
Publicado: (2020)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
por: Seif, Farhad, et al.
Publicado: (2017)

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

The potential roles of JAK/STAT signaling in the progression of osteoarthritis
por: Zhou, Qingluo, et al.
Publicado: (2022)

JAK-STAT signaling in cardiomyogenesis of cardiac stem cells
por: Mohri, Tomomi, et al.
Publicado: (2012)

Leptin-Induced JAK/STAT Signaling and Cancer Growth
por: Mullen, McKay, et al.
Publicado: (2016)

JAK/STAT Pathway Targeting in Primary Sjögren Syndrome
por: Gandolfo, Saviana, et al.
Publicado: (2022)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome
por: Li, Mucong, et al.
Publicado: (2023)

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
por: Hu, Qian, et al.
Publicado: (2023)

Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
por: Wei, Jun, et al.
Publicado: (2022)

The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies
por: Heimberger, Amy B.
Publicado: (2011)

The JAK/STAT signaling pathway: from bench to clinic
por: Hu, Xiaoyi, et al.
Publicado: (2021)

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
por: de Freitas, Renata Mendes, et al.
Publicado: (2015)

TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance
por: Ding, Zonghui, et al.
Publicado: (2020)

The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
por: Morris, Rhiannon, et al.
Publicado: (2021)

JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation
por: Satou, Ryousuke, et al.
Publicado: (2012)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Computational models of the JAK1/2-STAT1 signaling
por: Gambin, Anna, et al.
Publicado: (2013)

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis
por: Malemud, Charles J.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u81ncaa27sitao6ao51579t4l2